Chronic Disease
Chronic disease research requires different thinking
Successfully bringing chronic disease therapies to market means navigating a crowded research landscape. Our end-to-end solutions and deep therapeutic expertise can enable you to reach patients earlier, reduce trial burden and generate the evidence you need to differentiate your product.
Navigating a competitive and complex ecosystem
Developing a chronic disease therapy comes with specific challenges driven by a complex research environment.
Our experienced teams understand these challenges and can bring the right solutions together to successfully:
- Navigate trial competition
- Manage long timelines and cumulative complexity
- Reach and retain patients
- Collate fragmented data across phases and sources
- Anticipate commercial launch difficulties
- Ensure real-world representation and effectiveness
- Discover evidence gaps before it is too late
- Differentiate your product
Unlocking the power of primary care in chronic disease research
As chronic disease trials become more competitive and complex, many eligible patients remain outside the reach of clinical research. Drug developers often utilize the same research sites, patient populations and geographic locations, resulting in both site and patient recruitment challenges.
Access our white paper to learn how integrating primary care and community-based practices can expand patient and site access and increase participation in chronic disease trials.
Modernizing chronic disease trials through digital transformation
Explore how wearables, remote monitoring and decentralized trial models can help you reduce patient burden, support engagement and capture more continuous, meaningful data in chronic disease trials. This interactive e-book shares how digitally enabled approaches can strengthen evidence generation and support more informed decisions across long-term studies.
Beyond weight loss: Obesity trial design for real-world patient and payer impact
To successfully bring an obesity therapy to market, drug developers must generate evidence that balances scientific rigor with real-world relevance. Combining purposeful endpoint selection, patient-centric strategies and an integrated approach to evidence generation, developers can create a package that resonates with regulators, payers and patients alike. Watch as our experts explore innovative approaches to designing obesity trials that demonstrate value beyond weight loss.
Leveraging our deep experience across key therapeutic areas
In the past five years, our teams have supported:
respiratory studies
metabolic and endocrinology studies
cardiovascular studies
nephrology studies
Providing expert insights to propel chronic disease trials
FAQs
Our team provides access to the right patients through consistent, community-connected trial models designed to reach diverse and representative populations. Our capabilities combine community relationships, scalable trial delivery and patient engagement strategies that strengthen trust and support clinical research participation.
Our capabilities allow you to improve retention in long-term chronic disease trials by designing studies that fit into patients’ everyday care. Our patient-centered trial models support ongoing engagement, reduce participation burden, and improve retention and data quality throughout the study.
Our experts manage complex longitudinal data by integrating clinical data, real-world evidence, and advanced analytics into a connected evidence approach. Our capabilities enable earlier, more confident decisions across the product lifecycle.
We support product differentiation through evidence strategies that demonstrate the value of your therapy and how it compares with currently available treatments. This approach helps identify meaningful differentiators, generate supporting evidence, and communicate therapy value across the product lifecycle.